Skip to content

Efficacy of intraoperative intracameral mydriatic solution for pupillary dilatation in cataract surgery

Efficacy of intraoperative intracameral mydriasis in cataract surgery - A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053967
Enrollment
80
Registered
2023-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H251- Age-related nuclear cataract

Interventions

Intervention1: intracameral mydriatic: Efficacy of intraoperative intracameral mydriasis Intervention2: intracameral mydriatics and topical mydriatic eye drops: injection of mydriatic solution through

Sponsors

IndhujaS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with pupil diameter > 6mm during preoperative evaluation

Exclusion criteria

Exclusion criteria: Pseudoexfoliation, rigid pupil, senile miosis, past history of uveitis, ocular trauma, known allergy to any component of medicines used, glaucoma, corneal opacities, diabetes mellitus, drug intake like tamsulosin, complications during surgery - iris trauma, vitreous loss

Design outcomes

Primary

MeasureTime frame
pupillary diameterTimepoint: pupillary diameter before surgery, at the time of intraocular lens implantation and at the end of surgery

Secondary

MeasureTime frame
sustainability of pupil dilatationTimepoint: at the end of surgery

Countries

India

Contacts

Public ContactIndhujaS

Sri Manakula Vinayagar Medical College and Hospital

bwadwekar@yahoo.com9626249484

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026